Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)

NCT02230254 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02230254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 9, 2014
Completion date
July 31, 2015
Enrollment
101 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis